摘要
猴痘(Mpox)是一种由猴痘病毒(MPXV)感染引起的疾病,目前国际上没有针对猴痘病毒的特异性治疗药物,应用的抗病毒药物及疫苗既往主要用于治疗和预防天花等正痘病毒属相关疾病,抗病毒药物主要包括特考韦瑞、西多福韦、布林西多福韦等;疫苗主要使用ACAM2000、MVA-BN、LC16等,能够较好治疗和预防猴痘疾病的发生与发展。在无特效药物且无更有效、更安全疫苗的前提下,这些药物与疫苗可在早期治疗及预防中应用,以缓解猴痘病毒带来的临床症状,降低重症率和死亡率。本文从作用机制、临床试验、安全性等方面对抗病毒药物及疫苗进行论述,以期为我国猴痘的治疗和预防提供参考。
Monkeypox(Mpox)is a disease caused by infection with the monkeypox virus(MPXV).There is no specific therapeutic drug for monkeypox virus in the world,and antiviral drugs and vaccines are primarily used for the treatment and prevention of smallpox and other orthopoxviral diseases.The antiviral drugs mainly include Teicovirimat,Cidofovir,Brincidofovir,while vaccines mainly use ACAM2000,MVA-BN,and LC16,which have shown effectiveness in treating and preventing Mpox.Currently,Given the absence of a specific drug and a more effective and safer vaccine,these drugs and vaccines can be used in early treatment and prevention to alleviate clinical symptoms caused by the monkeypox virus,reducing the rate of severe disease and mortality.The thesis was discussed in terms of antiviral drugs and vaccines mechanism of action,clinical trials and safety to study the antiviral drugs and vaccines currently used internationally for the treatment of Mpox,with a view to providing reference for the treatment and prevention of Mpox in China.
作者
高旭
彭金娥
李兴旺
张伟
GAO Xu;PENG Jin’e;LI Xingwang;ZHANG Wei(Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China;Department of Pharmacy,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China)
出处
《中国药物警戒》
2024年第1期111-116,共6页
Chinese Journal of Pharmacovigilance
基金
国家重点研发计划(2022YFF1203201,2021YFC1712901)
国家中医药传承创新团队项目(ZYYCXTD-C-202006)
高层次公共卫生技术人才建设项目培养计划(学科骨干-02-31)。
关键词
猴痘
猴痘病毒
天花
抗病毒药物
疫苗
mpox
monkeypox virus
smallpox
antiviral drugs
vaccine
